Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728

Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30488-7 · Cited by 2,475

Against which human papillomavirus types shall we vaccinate and screen? the international perspective

Muñóz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjosé, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,095

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

Li, N., Franceschi, S., Howell‐Jones, R., Snijders, P. J. F., & Clifford, G. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25396 · Cited by 1,067

PROPORTION OF DISEASE CAUSED OR PREVENTED BY A GIVEN EXPOSURE, TRAIT OR INTERVENTION1

MIETTINEN, O. S. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121617 · Cited by 1,036

Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer

Guan, P., Howell‐Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., & Clifford, G. M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27485 · Cited by 927

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

SCHIFFMAN, M. H., Clifford, G. M., & Buonaguro, L. (2009) · Infectious Agents and Cancer · doi:10.1186/1750-9378-4-8 · Cited by 463

One virus, one lesion—individual components of CIN lesions contain a specific HPV type

Quint, W. G. V., Jenkins, D., Molijn, A. C., Struijk, L., van de Sandt, M. M., Doorbar, J., Mols, J., HOOF, C. V., Hardt, K., Struyf, F., et al. (2011) · The Journal of Pathology · doi:10.1002/path.3970 · Cited by 196

Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer

Clifford, G. M., Tully, S., & Franceschi, S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix135 · Cited by 196

Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants

Wentzensen, N., SCHIFFMAN, M. H., Dunn, T., Zuna, R. E., Gold, M. A., Allen, R. A., Zhang, R., Sherman, M. E., Wacholder, S., Walker, J. L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24528 · Cited by 186

Colposcopy Outcomes in Women with First Episode of Borderline Squamous Cells Cytology and High-risk Human Papillomavirus Positivity: A Retrospective Cohort Study

Rajagopal, R. (2026) · Journal of Preventive Diagnostic and Treatment Strategies in Medicine · doi:10.4103/jpdtsm.jpdtsm_84_26

Multi-scale Transcriptional Characterization of HPV16 and HPV18 in Cervical Cancer: Host Pathway Alterations and Links With Viral Gene Expression ProgramsPreprint

Ishihara, M. A., Valeriano, M. M. M., Oliveira, N., Mamede, I., Gama, L. C. D. M., Cunha, A. F., de Castro, Í. M. S., Vásquez, F., Nishiyama, M. Y., Setúbal, J. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.30.755713

HPV vaccination and cervical cancer deaths: from incidence reduction to mortality prevention

Alkhanafsa, M., Wafi, J., Deek, S. M. S., & abdalhadi, A. (2026) · Clinical Cancer Bulletin · doi:10.1007/s44272-026-00074-2

Ecological and inferred functional landscape of the cervicovaginal microbiome in relation to HPV infection and disease in Kenyan womenPreprint

Molina, M. A., Kosgei, N., Akinyi, I., Tavernier, L., Hassan, S. S., Stosic, M. S., Broeck, D. V., Mabeya, H., & Mühr, L. S. A. (2026) · Research Square · doi:10.21203/rs.3.rs-11267936/v1

Pre-pregnancy BMI and hypertensive disorders of pregnancy in Japan: population burden and simulated BMI reduction scenarios for preconception and interpregnancy care

Tano, S., Fujito, S., Inamura, T., Fuma, K., Matsuo, S., Katsuki, S., Yoshihara, M., Yamashita, M., Kotani, T., Kajiyama, H., et al. (2026) · Hypertension Research · doi:10.1038/s41440-026-02847-7

Beyond HPV16/18: genotype distribution of high-risk HPV and cycle threshold values in cervical carcinogenesis spectrum

Bostancı, E. İ., KOOHNAVARD, S., Yiğit, S., Çalışkan, E., & Bozdayı, G. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2746866

HPV genotype diversity and co-infection burden among cervical cancer patients: implications for viral surveillance and vaccine coverage

Siwach, K., Chauhan, M. B., Narwal, S., Kaushik, R., Sharma, A., Rohilla, G., Khatri, N., & Vashist, M. (2026) · VirusDisease · doi:10.1007/s13337-026-00996-4

Controlled Trial of Cervical Cancer Screening Frequency Among Human Papillomavirus Vaccinated Women II : Cervical Pre‐Cancer End‐Points by Specific Non‐Vaccine HPV Types

Lehtinen, M., Llobet, M. O., Eriksson, T., Baussano, I., Elfström, K. M., Ghaderi, M., Gray, P. G., Harjula, K., Heikkilä, K., Hokkanen, M., et al. (2026) · International Journal of Cancer · doi:10.1002/ijc.70753

Chlamydia trachomatis co-infection and cervical cancer risk in HPV-positive women: a cross-sectional and histological case-control study

Zhou, Y., Lei, W., Yang, Y., & Li, Z. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.109190

From HPV Detection to Cancer Prevention: The Role of Infection Persistence, Genotype, and Anatomical Site in HPV-Associated Cancers

Jouya, S., Shahabinia, Z., Abusalah, M. A. H., Mazidimoradi, A., Allahqoli, L., Salehiniya, H., & Lee, D. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15208098

Cross-protection and type-replacement over the 17 years after human papillomavirus vaccine introduction in young women

Kahn, J. A., Ermel, A. C., Ding, L., DeSieghardt, A., Yao, S., Brown, D. R., Dagnall, C. L., Bhatia, A., & Franco, E. L. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.129244

Shifting High-Risk HPV Genotype Patterns in Histologically Confirmed Cervical HSIL: Temporal Changes and Differential Distribution in Invasive Squamous Cell Carcinoma

del Arco, C. D., Mena, M. R., Calles, S. R., Botía, F. D., del Amo, M. B., Martínez, R. G., & Ortega, L. M. (2026) · Life · doi:10.3390/life16101760

Contemporary High-risk Human Papillomavirus Genotype Distribution and Associated Cytologic Findings Using Extended Human Papillomavirus Genotyping

Wilson, K. R., Maharjan, D., Shuler, B. L., Randolph, M. L., Howell, J. M., Frain, B. M., & Segura, S. E. (2026) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000993

Revolutionising Cervical Cancer Screening: Role of Truenat HPV DNA Point-of-Care Testing

Diouf, A., Sow, D. B., Sarr, C. C. T., & Mbaye, M. (2026) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2026.1610140

Therapeutic HPV16 E7 vaccination with CD137 agonism induces tumor regression and durable immunity in mice

Ou, Y., Lu, W., Zhao, H., Demetrious, C., Zhang, Q., 郑秋杰, Jiang, Y., Wan, P. K.-T., O’Neill, E. E., Zhang, L., et al. (2026) · iScience · doi:10.1016/j.isci.2026.118018

Baseline HPV16 status and genotype multiplicity independently predict subsequent high-grade cervical lesions in HR-HPV-positive women referred for colposcopy with negative or low-grade cytology: A prospective cohort study

Gardella, B., Dominoni, M., Pano, M. R., Lovotti, A., Cesari, S., Fiandrino, G., Alberizzi, P., & Spinillo, A. (2026) · Gynecologic Oncology · doi:10.1016/j.ygyno.2026.10.025

Towards a sequential microbiome therapy for HPV-associated cervicovaginal dysbiosis

Molina, M. A., Zhang, Y., Steenbergen, R. D. M., Melchers, W. J. G., & Du, J. (2026) · Communications Biology · doi:10.1038/s42003-026-11208-6

Age-specific HPV genotype distribution and associations with cervical lesions and vaginal microecological status in Northeast China: a retrospective study of 73,828 individuals

He, Y., Pan, Y., Sheng, Z., Liu, Y., Hao, S., Tong, W., & Jiang, Y. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1993128

Causal Attribution of Human Papillomavirus Types to Invasive Cervical Cancer Worldwide: A Systematic Analysis of the Global LiteraturePreprint

Wei, F., Georges, D., Man, I., Baussano, I., & Clifford, G. M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4692586 · Cited by 4

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728

HPV genotypes: implications for worldwide cervical cancer screening and vaccination

de Sanjosé, S. (2010)

Identification of HPV genotypes causing cervical precancer using tissue‐based genotyping

Venetianer, R., Clarke, M. A., van der Marel, J., Tota, J. E., SCHIFFMAN, M. H., Dunn, S. T., Walker, J. L., Zuna, R. E., Quint, W. G. V., & Wentzensen, N. (2020) · International Journal of Cancer · doi:10.1002/ijc.32919 · Cited by 23

Ranking the attribution of high-risk genotypes among women with cervical precancers and cancers: a cross-sectional study in Ningbo, China

Chen, S., Hu, S., Yin, J., Yu, W., Zhang, X., Deng, X., Ding, H., Zhang, J., Song, Y. Y., Wang, Q., et al. (2024) · Infectious Agents and Cancer · doi:10.1186/s13027-024-00598-z · Cited by 1